Xcout Intel
AbelZeta competitors & alternatives
The 12 closest competitors and alternatives to AbelZeta among biotechnology companies — ranked by similarity to what AbelZeta actually does, not by market-cap band.
Subscribe to see AbelZeta’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About AbelZeta
AbelZeta is a global clinical-stage biopharmaceutical company pioneering T cell-based therapies targeting cancer, inflammation, and immunological issues, with centers in Rockville, Maryland and Shanghai, China.
AbelZeta at a glance
AbelZeta is a biotechnology company headquartered in United States. It has raised at least $120M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $1M in November 2025. Xcout tracks 9 named people at AbelZeta, including Tony (Bizuo) Liu (Chairman and CEO).
AbelZeta leadership
- Tony (Bizuo) LiuChairman and CEO
- Andrew ChanChief Legal Officer
- Yihong YaoChief Scientific Officer
- Jiaqi HuangSenior Vice President, Translational Medicine
- Michael HavertSenior Vice President, Regulatory Affairs
- Hong YiVice President, Technology
3 more named people on record for AbelZeta, with roles, board committees and tenure — see the full roster →
AbelZeta funding rounds
At least $120M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $1M | 6 named | |
| Series A | $120M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 AbelZeta competitors
Ranked by semantic similarity — how close each company is to AbelZeta by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
CBMG Holdings, formerly known as Cellular Biomedicine Group, is a clinical-stage biopharmaceutical company specializing in the development of immunotherapies for cancers and stem cell therapies. The company focuses on immune cell therapies and T cell-based therapeutics. It has subsequently announced a name change to AbelZeta Pharma, Inc.
Similar biotechnology company
Arcellx, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to developing innovative immunotherapies and cell therapies for cancer patients.
Similar biotechnology company
ImmuXell Biotechnology is a clinical-stage biopharmaceutical innovation company headquartered in Shanghai, China. Founded in 2021, the company focuses on developing novel immune cell therapies targeted at treating solid tumor cancers.
Similar biotechnology company
Viela Bio, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to the discovery, development, and commercialization of novel therapies for autoimmune and severe inflammatory diseases.
Biotech
Tessa Therapeutics is a clinical-stage biotechnology company with its global headquarters in Singapore. The company focuses on developing next-generation cell therapies for cancer and opened a commercial-scale cell therapy manufacturing facility in Singapore in 2020.
Similar biotechnology company
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Similar biotechnology company
Innovative Cellular Therapeutics is a China-based biotechnology company focused on developing cellular immunotherapies, particularly CAR-T therapies for cancer. It serves patients with hematologic and potentially solid-tumor cancers through clinical development and commercialization of engineered cell therapies.
Similar biotechnology company
Adicet Bio, Inc. is a public biopharmaceutical company headquartered in Redwood City, California, specializing in the development of off-the-shelf gamma delta T cell therapies.
Similar biotechnology company
Tiankeya (also known as Beijing TCR Cure Biopharma Technology Co., Ltd.) is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in China, with operations in China and the United States. The company focuses on the innovation, development, and clinical translation of engineered T cell and immune cell therapies to treat cancer and solid tumors.
Similar biotechnology company
BriSTAR Immunotech Limited is a clinical-stage cell therapy company actively developing universal cell therapies with a differentiated product pipeline and offices in Beijing and Suzhou.
Biotech
Excalipoint Therapeutics is a clinical-stage biotechnology company headquartered in Shanghai, China. The firm is dedicated to developing next-generation T-cell engager (TCE) therapies and unlocking the therapeutic potential of T-cell based treatments.
Similar biotechnology company
Immunomic Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland, that develops innovative immune therapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of AbelZeta and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for AbelZetaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →